Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)
Radiation Oncology, pp. 1-9, 2019.
Rectal cancer Neoadjuvant chemoradiotherapy Intensity-modulated radiation therapy
This study was designed to explore whether an intensified chemoradiotherapy (CRT) led to a better clinical outcome in locally advanced rectal cancer. Patients with stage II/III rectal cancer were randomly allocated to receive either pelvic intensity-modulated radiation therapy (IMRT) of 50 Gy/25Fx concurrently with capecitabine and oxalip...More
Full Text (Upload PDF)
PPT (Upload PPT)